WO2013013240A3 - Composés macrocycliques et compositions associées et procédés d'utilisation - Google Patents

Composés macrocycliques et compositions associées et procédés d'utilisation Download PDF

Info

Publication number
WO2013013240A3
WO2013013240A3 PCT/US2012/047863 US2012047863W WO2013013240A3 WO 2013013240 A3 WO2013013240 A3 WO 2013013240A3 US 2012047863 W US2012047863 W US 2012047863W WO 2013013240 A3 WO2013013240 A3 WO 2013013240A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositons
methods
macrocyclic compounds
compounds
macrocyclic
Prior art date
Application number
PCT/US2012/047863
Other languages
English (en)
Other versions
WO2013013240A2 (fr
Inventor
Lijun Sun
James Barsoum
Ronald WESTER
Original Assignee
Theracrine, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theracrine, Inc. filed Critical Theracrine, Inc.
Publication of WO2013013240A2 publication Critical patent/WO2013013240A2/fr
Publication of WO2013013240A3 publication Critical patent/WO2013013240A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La présente invention concerne des composés et des compositions, qui peuvent être utilisés, par exemple, pour traiter un cancer.
PCT/US2012/047863 2011-07-21 2012-07-23 Composés macrocycliques et compositions associées et procédés d'utilisation WO2013013240A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161510177P 2011-07-21 2011-07-21
US61/510,177 2011-07-21

Publications (2)

Publication Number Publication Date
WO2013013240A2 WO2013013240A2 (fr) 2013-01-24
WO2013013240A3 true WO2013013240A3 (fr) 2013-07-11

Family

ID=47558755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/047863 WO2013013240A2 (fr) 2011-07-21 2012-07-23 Composés macrocycliques et compositions associées et procédés d'utilisation

Country Status (1)

Country Link
WO (1) WO2013013240A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210330646A1 (en) * 2018-08-27 2021-10-28 Spinogenix, Inc. Fascin binding compounds for spinogenesis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037852A1 (en) * 2003-03-28 2007-02-15 Danishefsky Samuel J Migrastatin analogs and uses thereof
US20090124662A1 (en) * 2004-05-25 2009-05-14 Danishefsky Samuel J Migrastatin analogs in the treatment of cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037852A1 (en) * 2003-03-28 2007-02-15 Danishefsky Samuel J Migrastatin analogs and uses thereof
US20090124662A1 (en) * 2004-05-25 2009-05-14 Danishefsky Samuel J Migrastatin analogs in the treatment of cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANQUETIN G. ET AL.: "Synthesis of Novel Migrastatin and Dorrigocin A Analogu es from D-Glucal", CHEMISTRY A EUROPEAN JOURNAL, vol. 14, no. 5, 2008, pages 1592 - 1600 *

Also Published As

Publication number Publication date
WO2013013240A2 (fr) 2013-01-24

Similar Documents

Publication Publication Date Title
EP2714081A4 (fr) Méthodes, compositions et trousses pour le traitement du cancer
EP2523944A4 (fr) Composés et compositions pour l'amélioration de la cognition, leurs procédés de fabrication, et méthodes de traitement
EP2721033A4 (fr) Composés, compositions pharmaceutiques de ceux-ci et utilisation de ces composés comme inhibiteurs mutants d'idh1 dans le traitement de cancers
WO2014052836A3 (fr) Procédés et compositions de traitement d'une infection
WO2013056148A3 (fr) Procédés d'utilisation d'antagonistes de scd1
WO2013119916A3 (fr) Composés destinés au traitement de l'amyotrophie spinale
WO2013114367A8 (fr) Anticorps de c10rf32 et leurs utilisations pour traiter le cancer
MY177344A (en) Compounds and their methods of use
WO2012149472A9 (fr) Procédés, compositions et trousses pour traiter et prévenir des états neurologiques
WO2014164704A3 (fr) Composés et compositions utilisables en vue du traitement du cancer
WO2012054862A9 (fr) Agents, compositions et méthodes pour traiter le prurit et des troubles dermiques associés
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
EP2542584B8 (fr) Méthodes de traitement du cancer du pancréas
WO2012122383A3 (fr) Inhibiteurs de pi3 kinase et leurs utilisations
WO2012103810A1 (fr) Certaines entités chimiques, compositions et procédés
EP2531025A4 (fr) Méthode de traitement des infections fongiques, compositions fongicides et leur utilisation
MX354988B (es) Formulaciones de anticuerpo y metodos.
MY157341A (en) Methods and compositions for treating lung cancer
WO2011129936A3 (fr) Compositions et procédés pour la prévention et le traitement du cancer
EP2996721A4 (fr) Méthodes et compositions pour pronostiquer, diagnostiquer et traiter un cancer exprimant adam8
WO2013120022A3 (fr) Traitement de l'hypoglycémie
EP2725901A4 (fr) Compositions, méthodes et nécessaires pour traiter la leucémie
WO2012017321A3 (fr) Traitement de la dyslipidémie
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
WO2013052108A3 (fr) Méthodes et compositions destinées à traiter et à diagnostiquer un cancer de l'ovaire

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12815296

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12815296

Country of ref document: EP

Kind code of ref document: A2